Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Durham

Showing results (31-40 of 562) with videos related to

Pageof 57
Sort By:
Immunology and Allergy Clinics of North America|May 3, 2011
Mechanisms of sublingual immunotherapyGuy Scadding, Stephen R Durham
Allergy|February 1, 2005
Epidemiological characterization of the intermittent and persistent types of allergic rhinitisV Bauchau, S R Durham
Current Allergy and Asthma Reports|March 29, 2002
Local IgE synthesis in allergic rhinitis and asthmaLyn Smurthwaite, Stephen R Durham
Allergy|July 11, 2007
Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockageS R Durham, B Riis
Human Vaccines & Immunotherapeutics|October 26, 2012
Allergen immunotherapy for allergic respiratory diseasesAntonio Cappella, Stephen R Durham
The World Allergy Organization Journal|January 4, 2013
Allergen immunotherapy: a centenary celebrationStephen R Durham, Harold Nelson
The Journal of Allergy and Clinical Immunology|April 10, 2007
Allergic rhinitis and its impact on asthma update: allergen immunotherapyGiovanni Passalacqua, Stephen R Durham,
The European Respiratory Journal|November 2, 2004
Prevalence and rate of diagnosis of allergic rhinitis in EuropeV Bauchau, S R Durham
Allergy and Asthma Proceedings|July 12, 2022
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapyMartin Penagos, Stephen R Durham
The Journal of Antimicrobial Chemotherapy|November 1, 1980
Human pharmacology and tissue levels of CGP 7174/E: a new antipseudomonal cephalosporinS R Durham, R Wise
Pageof 57

Showing results (31-40 of 562) with videos related to

Sort By:
Pageof 57
Immunology and Allergy Clinics of North America|May 3, 2011
Mechanisms of sublingual immunotherapyGuy Scadding, Stephen R Durham
Allergy|February 1, 2005
Epidemiological characterization of the intermittent and persistent types of allergic rhinitisV Bauchau, S R Durham
Current Allergy and Asthma Reports|March 29, 2002
Local IgE synthesis in allergic rhinitis and asthmaLyn Smurthwaite, Stephen R Durham
Allergy|July 11, 2007
Grass allergen tablet immunotherapy relieves individual seasonal eye and nasal symptoms, including nasal blockageS R Durham, B Riis
Human Vaccines & Immunotherapeutics|October 26, 2012
Allergen immunotherapy for allergic respiratory diseasesAntonio Cappella, Stephen R Durham
The World Allergy Organization Journal|January 4, 2013
Allergen immunotherapy: a centenary celebrationStephen R Durham, Harold Nelson
The Journal of Allergy and Clinical Immunology|April 10, 2007
Allergic rhinitis and its impact on asthma update: allergen immunotherapyGiovanni Passalacqua, Stephen R Durham,
The European Respiratory Journal|November 2, 2004
Prevalence and rate of diagnosis of allergic rhinitis in EuropeV Bauchau, S R Durham
Allergy and Asthma Proceedings|July 12, 2022
Long-term efficacy of the sublingual and subcutaneous routes in allergen immunotherapyMartin Penagos, Stephen R Durham
The Journal of Antimicrobial Chemotherapy|November 1, 1980
Human pharmacology and tissue levels of CGP 7174/E: a new antipseudomonal cephalosporinS R Durham, R Wise
Pageof 57